Clinical Trial Update: Safety and Efficacy of Remimazolam in ASA III and IV Patients Undergoing Colonoscopy [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of Remimazolam in high-risk ASA III/IV patients undergoing colonoscopy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colonoscopy-related Sedation

Drugs mentioned

• Remimazolam (remimazolam)

Snippet

Sponsor: Paion UK Ltd. | Conditions: Colonoscopy | Phase 3 | Status: COMPLETED | Results posted: 2019-01-23